UPMC JAMESON — History
CCN 390016 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$115M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
-30.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $100M | $112M | $115M | +3.1% | +7.5% |
| Operating Expenses | $122M | $136M | $150M | +10.2% | +10.5% |
| Operating Margin | -22.9% | -21.6% | -30.0% | -38.7% | +0.0% |
| Net Income | $-23M | $-24M | $-34M | -43.1% | +0.0% |
| Licensed Beds | 134 | 134 | 134 | +0.0% | +0.0% |
| Total Patient Days | 21,161 | 21,283 | 22,090 | +3.8% | +2.2% |
| Medicare Day % | 23% | 21% | 22% | +2.0% | -2.9% |
| Medicaid Day % | 1% | 2% | 1% | -37.6% | +5.8% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +15.5% ($100M → $115M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-30.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $123M | -33.5% |
| FY2024 (proj) | $131M | -37.1% |
| FY2025 (proj) | $138M | -40.6% |